Peak Bio, Inc. Share-based Payment Arrangement, Expense
Peak Bio, Inc. reported Share-based Payment Arrangement, Expense of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-11-12
- Peak Bio, Inc. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Peak Bio, Inc. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Peak Bio, Inc. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $30.51K, a 81.51% decline year-over-year.
- Peak Bio, Inc. share-based payment arrangement, expense for the quarter ending 2023-12-31 was -$99.82K, a 178.17% decline year-over-year.
- Peak Bio, Inc. share-based payment arrangement, expense for fiscal 2023 was $275.42K, a 50.82% decline from fiscal 2022.
- Peak Bio, Inc. share-based payment arrangement, expense for fiscal 2022 was $560.06K, a 11353.17% increase from fiscal 2021.
- Peak Bio, Inc. share-based payment arrangement, expense for fiscal 2021 was $4.89K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $30.51K 10-Q · filed 2024-11-12 | -$69.31K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-23 | $30.51K 10-Q · filed 2024-08-23 | -$69.31K derived: sum of 3 quarters · filed 2024-08-23 | $7.48K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $30.51K 10-Q · filed 2024-08-23 | -$69.31K derived: sum of 2 quarters · filed 2024-08-23 | $7.48K derived: sum of 3 quarters · filed 2024-11-12 | $140.92K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | -$99.82K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | -$23.03K derived: sum of 2 quarters · filed 2024-11-12 | $110.41K derived: sum of 3 quarters · filed 2024-11-12 | $275.42K 10-K · filed 2024-08-06 |
| 2023-09-30 | $76.80K 10-Q · filed 2024-11-12 | $210.23K derived: sum of 2 quarters · filed 2024-11-12 | $375.24K 10-Q · filed 2024-11-12 | $502.94K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $133.44K 10-Q · filed 2024-08-23 | $298.44K 10-Q · filed 2024-08-23 | $426.14K derived: sum of 3 quarters · filed 2024-08-23 | $584.71K derived: sum of 4 quarters · filed 2024-08-23 |
| 2023-03-31 | $165.01K 10-Q · filed 2024-08-23 | $292.70K derived: sum of 2 quarters · filed 2024-08-23 | $451.28K derived: sum of 3 quarters · filed 2024-08-23 | $617.05K derived: sum of 4 quarters · filed 2024-08-23 |
| 2022-12-31 | $127.70K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | $286.27K derived: sum of 2 quarters · filed 2024-08-06 | $452.05K derived: sum of 3 quarters · filed 2024-08-06 | $560.06K 10-K · filed 2024-08-06 |
| 2022-09-30 | $158.57K 10-Q · filed 2024-06-25 | $324.35K derived: sum of 2 quarters · filed 2024-06-25 | $432.36K 10-Q · filed 2024-06-25 | |
| 2022-06-30 | $165.78K 10-Q · filed 2023-08-18 | $273.79K 10-Q · filed 2023-08-18 | ||
| 2022-03-31 | $108.01K 10-Q · filed 2023-07-12 | |||
| 2021-12-31 | $4.89K 10-K · filed 2023-06-29 |